Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.75
Delayed Data
As of Jul 27
 0.00 / 0.00%
Today’s Change
0.97
Today|||52-Week Range
2.02
-7.41%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.75
Today’s open1.75
Day’s range1.75 - 1.76
Volume349,181
Average volume (3 months)511,228
Market cap$263.8M
Dividend yield--
Data as of 4:03pm ET, 07/27/2015

Growth & Valuation

Earnings growth (last year)+31.43%
Earnings growth (this year)+16.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+454.99%
P/E ratioNM
Price/Sales44.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVLSNivalis Therapeutics...+0.10+0.55%
GALEGalena Biopharma Inc-0.10-6.21%
DRNADicerna Pharmaceutic...-0.32-2.46%
TRVNTrevena Inc-0.28-4.31%
Data as of 3:59pm ET, 07/27/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$6.3M
Annual profit (last year)-$35.7M
Net profit margin-569.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers